Biotechnology

Filter

Current filters:

None

Popular Filters

1910 to 1934 of 2315 results

Erythropoietin market in Japan to reach $1.54 billion by 2015

20-05-2012

The erythropoietin market in Japan is forecast to reach $1.54 billion by 2015 by analysts at TechNavio.…

Asia-PacificBiotechnologyGenericsMarkets & MarketingNephrology and HepatologyPatents

Human Genome adopts Rights Plan to thwart GSK hostile takeover

18-05-2012

US biotech company Human Genome Sciences (Nasdaq: HGSI) said yesterday that, after carefully reviewing…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Optimism and concerns of Netherlands' Biotech industry

17-05-2012

Major trends and developments in the Dutch biotechnology sector, mainly based on the expectations voiced…

BiotechnologyEuropeFinancialRegulationResearch

Blueprint to boost R&D for diseases of the developing world

17-05-2012

A new study, commissioned by the International Federation of Pharmaceutical Manufacturers and Associations…

BiotechnologyFinancialGlobalPharmaceuticalResearch

China's Hisun gains access to Enzon technology

17-05-2012

US biotech firm Enzon Pharmaceuticals (Nasdaq: ENZN) and Chinese drugmaker Zhejiang Hisun Pharmaceuticals…

Asia-PacificBiotechnologyEnzon PharmaceuticalsLicensingOncologyPEG-SN38PharmaceuticalZhejiang Hisun Pharma

Highlights of presentations planned for ASCO meeting

17-05-2012

Ahead of the annual American Society of Clinical Oncology (ASCO) meeting which takes place in Chicago…

AmgenBayerBiotechnologyBristol-Myers SquibbOncologyPharmaceuticalResearchSanofi

US FDA reviews NDAs faster than EU and Canadian regulators, contends new study

16-05-2012

a new study published on-line yesterday in the prestigious New England Journal of Medicine, the US Food…

BiotechnologyNorth AmericaPharmaceuticalRegulation

Biosimilars can save eight EU countries up to 33 billion euros on health care by 2020

16-05-2012

By 2020, eight countries in the European Union could save a cumulative total of between 11.8 billion…

BiotechnologyEuropeGenericsHealthcareNovartisPricingSandoz

Avalanche Biotech and Lonza link up on adeno-associated viral vectors for gene therapy

16-05-2012

Privately-held US firm Avalanche Biotechnologies and Switzerland-based contract manufacturer Lonza (SIX:…

Avalanche BiotechnologiesBiotechnologyLonzaOphthalmicsResearch

Contract manufacturing in India and China backed by government policies

16-05-2012

Contract Manufacturing Organizations (CMO) will reap the rewards as pharmaceutical production becomes…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceutical

GlaxoSmithKline buys full control of Cellzome

16-05-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has signed an agreement to fully acquire privately held Cambridge…

BiotechnologyCellzomeGlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Merck KGaA 1st-qtr 2012 sales rise but net profit plunges

15-05-2012

German drug major Merck KGaA (MRK: DE) this morning reported first-quarter 2012 results with 3.2% growth…

BiotechnologyFinancialMerck KGaAMerck SeronoPharmaceutical

Additional investment in New Zealand health welcomed by pharma trade group

15-05-2012

New Zealand Prime Minister John Key yesterday announced a number of new initiatives which came to an…

Asia-PacificBiotechnologyHealthcarePharmaceutical

PolyMedix stops trials of anticoagulant PMX-60056 on safety concerns

15-05-2012

US biotech firm PolyMedix (OTCBB: PYMX) has issued an update on its anticoagulant reversing agent PMX-60056,…

BiotechnologyCardio-vascularPolyMedixResearch

Study shows benefit of new maintenance therapy for multiple myeloma

14-05-2012

Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing…

BiotechnologyCelgenelenalidomideOncologyPharmaceuticalResearchRevlimid

FDA advisory thumbs up for Gilead's once-daily Quad for HIV

14-05-2012

There was more good news for Gilead Sciences (Nasdaq: GILD), the world's largest maker of HIV drugs,…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalQuadRegulation

Cell Therapeutics' Pixuvri cleared in EU for NHL

14-05-2012

US biotech firm Cell Therapeutics (Nasdaq and MTA: CTIC) last week received conditional marketing authorization…

BiotechnologyCell TherapeuticsEuropeOncologyPharmaceuticalPixuvriRegulation

UK's Proximagen boosted by US lorcaserin news with respect to its own obesity drug candidate

14-05-2012

UK-based biotechnology firm Proximagen (AIM: PRX) saw its shares leap 20.1% to 257.5 pence, on the back…

BiotechnologyMetabolicsProximagenRegulationResearch

Big pharma and biotech increasingly tackling rare and niche diseases, new report finds

13-05-2012

Rare and niche diseases are being increasingly spotlighted by pharmaceutical and biotechnology corporations…

BiotechnologyPharmaceuticalRare diseasesResearch

Oncologists backing of combo products supporting cytotoxic market

13-05-2012

The popularity of combination therapies in the treatment of cancer is set to increase, which will help…

BiotechnologyGemzarMarkets & MarketingOncologyPharmaceuticalTaxotere

US FDA warns on safety of Celgene's Revlimid; new Ph III trial results

11-05-2012

The US Food and Drug Administration this week issued a notification of an increased risk of second primary…

BiotechnologyCelgeneOncologyRegulationResearchRevlimid

High expectations for new US biosimilars following FDA guidance documents

10-05-2012

In light of the upcoming FDA guidance for biosimilar approval, Novation, health care supply chain expertise…

BiotechnologyGenericsNorth AmericaPricingRegulation

1910 to 1934 of 2315 results

Back to top